pidotimod has been researched along with Acute Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Liu, C; Liu, X; Zhao, N; Zhu, C | 1 |
Mameli, C; Zuccotti, GV | 1 |
Bedogni, G; Mameli, C; Pasinato, A; Picca, M; Pisanelli, S; Zuccotti, GV | 1 |
Alfano, S; Biolchini, A; Careddu, P; Zavattini, G | 1 |
1 review(s) available for pidotimod and Acute Disease
Article | Year |
---|---|
Pidotimod: a review of its pharmacological features and clinical effectiveness in respiratory tract infections.
Topics: Acute Disease; Animals; Humans; Immunologic Factors; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Risk Factors; Thiazolidines; Treatment Outcome | 2019 |
2 trial(s) available for pidotimod and Acute Disease
Article | Year |
---|---|
Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
Topics: Acute Disease; Adjuvants, Immunologic; Child Day Care Centers; Double-Blind Method; Female; Humans; Immunization; Incidence; Infant; Male; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Risk Reduction Behavior; Thiazolidines; Treatment Outcome | 2015 |
Pidotimod in the prophylaxis of recurrent acute tonsillitis in childhood.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Pyrrolidonecarboxylic Acid; Recurrence; Thiazoles; Thiazolidines; Tonsillitis | 1992 |
1 other study(ies) available for pidotimod and Acute Disease
Article | Year |
---|---|
Pidotimod: the past and the present.
Topics: Acute Disease; Adaptive Immunity; Adjuvants, Immunologic; Animals; Child; Child, Preschool; Cohort Studies; Disease Models, Animal; Female; Forecasting; Humans; Immunity, Innate; Incidence; Male; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Risk Factors; Secondary Prevention; Thiazolidines; Treatment Outcome | 2013 |